A disappointing summer for sun care sales has triggered a significant downturn for consumer goods conglomerate Edgewell Personal Care. The company, known for its Banana Boat and Wilkinson Sword brands, is facing investor skepticism after reporting dismal quarterly results that sent its shares tumbling. However, some strategic moves suggest potential recovery for patient investors.
Q3 Fiscal 2025 Results Spark Sell-Off
Edgewell’s third fiscal quarter proved challenging, with the company falling short of revenue expectations. It posted sales of $627.2 million, significantly below the anticipated $658.5 million and representing a 3.2% decrease year-over-year. The situation appeared more concerning when examining organic revenue, which declined by 4.2%.
The company’s adjusted earnings per share also disappointed, dropping to $0.92 from $1.22 in the comparable period. This fell well below the $1.01 per share that market analysts had projected. Management attributed the weak performance primarily to poor sun care product sales across North America and parts of Latin America due to unfavorable weather conditions. Consequently, net income plummeted 40.6% to $29.1 million.
Analyst Community Responds With Downgrades
Financial institutions quickly adjusted their outlooks for Edgewell following the earnings release:
- UBS maintained its neutral rating but reduced its price target from $28 to $21
- Barclays lowered its target price from $26 to $22
- Morgan Stanley upgraded the stock to “Equal Weight” while simultaneously cutting its target from $26 to $23
A single positive note emerged from Canaccord Genuity, which maintained its buy recommendation despite trimming its price target from $35 to $32. The firm characterized the stock as oversold in the current market.
Should investors sell immediately? Or is it worth buying Edgewell Personal Care?
Institutional Investors Show Diverging Strategies
The reaction from major investment firms presented a mixed picture during the market turmoil. While retail investors engaged in widespread selling, several institutional players actually increased their holdings:
- Charles Schwab Investment Management boosted its position by 7.8% to 881,101 shares
- Public Sector Pension Investment Board expanded its stake by 40.5% to 170,649 shares
- Nuveen LLC established a new position comprising 113,237 shares
This bullish sentiment wasn’t universal, however. Gabelli Funds reduced its exposure by 14.7%, highlighting the divided opinions on Edgewell’s recovery prospects.
Dividend Commitment Provides Stability
Despite the disappointing quarterly performance, Edgewell reaffirmed its commitment to shareholder returns. The company confirmed its quarterly dividend of $0.15 per share, payable in October. At the current share price, this distribution represents an attractive dividend yield of approximately 2.6%.
The coming quarters will determine whether the company’s sun care troubles were merely weather-related or indicative of deeper structural challenges. The consistent dividend policy may help maintain investor confidence as Edgewell navigates this difficult period.
Ad
Edgewell Personal Care Stock: Buy or Sell?! New Edgewell Personal Care Analysis from August 30 delivers the answer:
The latest Edgewell Personal Care figures speak for themselves: Urgent action needed for Edgewell Personal Care investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 30.
Edgewell Personal Care: Buy or sell? Read more here...